理特咨询：2024加速沙特阿拉伯生物技术行业发展报告（英文版）（24页）.pdf

1、ADVANCING BIOTECHNOLOGY&GENOMIC S IN SAUDI AR ABIABest practice strategies to develop the sector&maximize its impact2024CONTENTEXECUTIVE SUMMARY 31.THE GLOBAL GROWTH OF BIOTECHNOLOGY&GENOMICS 62.CURRENT STATUS OF BIOTECHNOLOGY&GENOMICS IN SAUDI ARABIA 83.ACCELERATING PROGRESS WITHIN SAUDI ARABIA 124

2、.KEY SUCCESS FACTORS TO DEVELOP SECTOR IN SAUDI ARABIA 16CONCLUSION 20We would like to acknowledge all those who contributed in the review of this Report,especially:Dr.Ulrica Sehlstedt,Farhan Mirza,and Dr.Ali Ayach.VIKAS KHARBANDAPartner,Healthcare&Life Sciences Practice Lead for Middle East and Sou

3、th East Asia Riyadh/DubaiDR.PATRICK LINNENBANKPartner,Healthcare&Life Sciences Practice Riyadh/DubaiDR.ANKITA GULATIPrincipal,Healthcare&Life Sciences Practice Dubai HARSHA AGARWALConsultant New Delhi2HARNESSING THE BENEFITS OF BIOTECHNOLOGY IN SAUDI ARABIAFueled by advances in emerging technologies

4、 such as precision medicine,1 ultra-targeted therapies,“omics,”2 and many more,the global biotechnology and genomics sector is expected to expand at a double-digit growth rate going forward.Having understood the potential of the sector,governments across the world are making concerted efforts to har

5、ness and develop their own biotechnology industries.Recognizing the opportunity,The Kingdom of Saudi Arabia(KSA)has already launched multiple initiatives to encourage the sectors growth within the country.While KSAs biotechnology industry is still at a relatively nascent stage,it is already seeing a

6、ctivity from different players,along with collaboration on projects such as the Saudi Genome Program,which provide a promising foundation for the future.However,while these efforts are a step in the right direction,success requires a clear vision with specific priority areas outlined.This includes i